enzalutamide,talazoparib
astellas,pfizer
['pcsm', 'brca', 'crpc']
dr. fizazi presenting more data in support of parpi combined with arsi in patients with brca mutations in front line mcrpc. os still immature but trending favorably. #pcsm #brca #asco2023 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.